Blog

EnSilica (LSE:ENSI) has raised approximately £14 million through an oversubscribed placing and subscription priced at 91 pence per share. The company will issue more than 15.3 million new shares to institutional investors, alongside a smaller subscription, with the proceeds earmarked to accelerate product development, fund new customer projects and support its growing contract pipeline across key semiconductor markets.

The capital raise has been structured in two stages due to the company’s existing share issuance authorities. The first tranche, worth £10.73 million, has already been conditionally arranged, while the remaining £3.27 million, together with a retail offer, is subject to shareholder approval later this month. The fundraising will also alter EnSilica’s shareholder register, increasing Esterhuyzen Limited’s holding to approximately 16.6% and slightly reducing Chief Executive Ian Lankshear’s percentage ownership. Admission of the new shares to AIM will also increase the company’s free float.

EnSilica’s investment outlook continues to be weighed down by weaker financial performance, including lower revenue, ongoing losses and declining free cash flow. While recent share price momentum has been positive, technical indicators suggest the stock may be entering overbought territory, increasing the risk of a short-term pullback. Valuation also remains challenging as the company is not yet profitable and does not currently pay a dividend.

More about EnSilica PLC

EnSilica PLC is a UK-based fabless semiconductor company specialising in the design of application-specific integrated circuits (ASICs). Its expertise spans radio frequency (RF), millimetre wave (mmWave), mixed-signal and complex digital integrated circuit design, serving customers across the space, communications, industrial and automotive sectors.

The company combines a portfolio of reusable intellectual property with silicon platform technologies to reduce development times and generate long-term supply revenues. EnSilica operates design centres in the UK, India, Brazil and Hungary, supporting customers with custom chip development for a range of advanced applications.

IXICO plc (LSE:IXI), a specialist in AI-powered neuroscience imaging and biomarker analytics, has raised its revenue expectations for the financial year ending 30 September 2026 following strong commercial performance. The company provides imaging contract research services to pharmaceutical companies, biotechnology firms, disease consortia and non-profit organisations developing treatments for neurological conditions, using its proprietary IXI platform to support global clinical trials in diseases including Alzheimer’s, Huntington’s and Parkinson’s.

The company now expects annual revenue of at least £8.0 million, exceeding previous forecasts and representing approximately 22% growth compared with FY2025. IXICO said the improved outlook reflects strong trading, new contract awards, project extensions and a broader mix of revenue streams. Management believes the performance demonstrates the success of the strategic plan launched in 2024, strengthening the company’s position in neuroscience imaging and reinforcing its role as a partner to drug developers seeking reliable imaging data and biomarker analysis for clinical research.

The investment outlook continues to be weighed down by ongoing losses and negative operating cash flow. However, these challenges are partly offset by improving commercial momentum, stronger operating leverage, high levels of contracted revenue visibility and a strengthened cash position following the company’s recent capital raise. Technical indicators remain positive, although the shares appear overbought, while valuation metrics continue to be affected by the absence of profitability and dividend payments.

More about IXICO plc

IXICO plc is a neuroscience imaging and biomarker analytics company that operates as an end-to-end Imaging Contract Research Organisation (iCRO) for global pharmaceutical and biotechnology clients. Through its proprietary AI-driven IXI platform, the company supports clinical trials targeting neurological diseases including Alzheimer’s, Huntington’s and Parkinson’s, helping improve the accuracy of biomarker measurement throughout the drug development process.

With more than two decades of experience in neurological disease research, IXICO has analysed hundreds of thousands of brain scans and established an extensive international network of specialist imaging centres. Its technology platform processes complex imaging data from multinational clinical studies, combining advanced artificial intelligence with scientific expertise to deliver reliable, reproducible insights for researchers and drug developers.

Forgent plc (LSE:FORG) has finished the first phase of drilling at its Peak Hills gold-copper project in Western Australia, marking another step forward in the evaluation of the Karalundi, Junction and Curleys prospects. The programme was designed to confirm historic exploration results, expand known mineralised zones and investigate additional targets to support a better understanding of the project’s resource potential.

The drilling campaign included 40 holes covering approximately 2,680 metres, using both aircore and reverse circulation methods to accommodate different geological conditions across the site. A total of 1,587 samples have been submitted to an independent laboratory in Perth for analysis, with assay results expected to guide the next stage of exploration and help determine the project’s future development potential.

The company’s outlook remains constrained by weak financial fundamentals, including continuing losses, leverage and negative cash flow. Technical indicators also remain unfavourable, reflecting a prolonged share price downtrend, while valuation metrics offer little support due to the absence of positive earnings and dividend data.

More about Forgent plc

Forgent plc is an AIM-listed company focused on energy transition opportunities alongside its mineral exploration activities. Its principal exploration asset is the Peak Hills gold-copper project in Western Australia, where the company currently holds a 51% interest and retains the option to increase its ownership to 99%. The project forms part of Forgent’s strategy to build exposure to metals that are expected to play an important role in the global energy transition.

Petards (LSE:PEG) has strengthened its order book after its subsidiary, Petards Joyce-Loebl (PJL), secured new contracts across its Rail and Defence divisions with a combined value of more than £0.9 million. The latest awards improve revenue visibility over the short and medium term and support activity across the current and next financial years.

Within the Rail division, PJL has been awarded a contract worth more than £0.5 million to provide its eyeTrain systems for installation on additional train sets within an existing fleet. Deliveries are scheduled to begin later in 2026, with the programme expected to be completed during 2027.

The Defence division has also won a £0.4 million contract from a UK prime contractor to supply proprietary safety equipment for military aerospace applications. Delivery of the order is expected to be completed before the end of 2026. The chairman said the new contracts strengthen the group’s order book for both the current and following financial years, reflecting improving momentum in the rail business while reinforcing Petards’ position in rail safety technology and defence electronics.

The company’s outlook is supported by improving financial stability, with stronger margins and positive free cash flow reported during 2025, alongside favourable technical indicators that show the shares trading above key moving averages. However, continued net losses and a mixed record of growth and returns continue to weigh on the overall investment case.

More about Petards Group PLC

Petards Group PLC is an AIM-listed developer of security, communications and surveillance technologies, operating primarily through its Petards Joyce-Loebl subsidiary in the North East of England. Its Rail division supplies safety and operational systems including automatic door monitoring, passenger camera solutions and AI-enabled PTeye technology, while the Defence division designs and manufactures rugged electronic control and communications equipment for the UK armed forces and major defence contractors.

The company’s Gateshead facility employs a specialist workforce of engineers, technicians and support staff, supporting advanced manufacturing in the region. With roots in the UK defence sector stretching back to the 1950s, Petards Defence has established expertise in military communications, engineering support, integrated logistics and electronic systems for complex defence programmes.

Transense Technologies (LSE:TRT) has announced a planned leadership transition that will see long-serving Chief Financial Officer and Company Secretary Melvyn Segal retire from his executive responsibilities at the company’s November 2026 AGM. Following his retirement, Segal will remain involved as a non-executive director for a further year to help ensure a smooth transfer of responsibilities. The Board said his contribution has played a key role in the company’s transformation and that the phased transition is intended to maintain continuity within the finance function.

As part of the succession plan, experienced chartered accountant Richard Michael Pearce will join the business as Finance Director on 1 September 2026. He will initially work alongside Segal in a non-board capacity before taking up a Board position when Segal formally steps down as CFO. Pearce brings extensive experience in growing listed companies and healthcare businesses, with the Board expecting his appointment to support Transense’s long-term expansion strategy and strengthen its financial leadership.

The company’s investment outlook continues to benefit from solid financial fundamentals, including revenue growth, strong gross margins, improving cash generation and low leverage, while its valuation remains relatively modest on a price-to-earnings basis. These strengths are tempered by weaker technical indicators, with the shares trading below key moving averages and momentum measures remaining negative.

More about Transense Technologies PLC

Transense Technologies PLC is an AIM-listed technology company based in Oxfordshire that develops advanced sensing and measurement solutions for demanding industrial applications. Through its SAWsense and Translogik divisions, the group supplies technologies to customers across the aerospace, automotive, industrial machinery and commercial vehicle tyre sectors, helping improve operational performance, efficiency and safety.

Its SAWsense business develops and licenses Surface Acoustic Wave sensor technology to major original equipment manufacturers, including GE Aerospace, Airbus and McLaren Applied. Meanwhile, Translogik provides connected tyre inspection systems to leading tyre manufacturers and fleet operators worldwide. The company also generates recurring royalty income from Bridgestone’s iTrack off-highway tyre monitoring platform under a long-term licensing agreement.

The Beauty Tech Group (LSE:TBTG) has increased its guidance for 2026 after delivering a strong first-half trading performance, with revenue expected to be significantly higher than the same period last year across its core business, major markets and sales channels. The company said continued investment in its operating model has improved profitability, leading to higher expectations for both revenue and adjusted EBITDA.

The Board now expects full-year revenue to reach at least £170 million, alongside adjusted EBITDA of £45 million, exceeding previous market forecasts of £161.7 million and £41.5 million respectively. Management attributed the improved outlook to rising international demand for its premium at-home beauty technology brands and a robust pipeline of upcoming product launches, which it believes will support further growth in the expanding beauty technology market.

More about The Beauty Tech Group Plc

The Beauty Tech Group Plc is a Cheshire-based company listed on the London Stock Exchange under the ticker LSE:TBTG. The business is a global specialist in the rapidly growing at-home beauty technology sector, designing, manufacturing and selling devices through its premium brands CurrentBody Skin, ZIIP Beauty and Tria Laser.

Its product portfolio incorporates technologies including LED light therapy, radiofrequency, microcurrent and laser treatments, enabling consumers to access professional-style beauty procedures at home. The company primarily serves customers through its direct-to-consumer e-commerce platforms while also distributing products through selected retail partners in the UK and international markets.

Halma (LSE:HLMA) has entered into an agreement to acquire Strasbourg-based Dreampath Diagnostics, a specialist in automated solutions for tracking, storing and managing patient tissue samples used in anatomical pathology laboratories.

Dreampath has developed a closed-platform system that combines hardware, software and recurring consumables to streamline complex laboratory workflows. Its technology is designed to improve sample traceability, minimise the risk of identification errors and increase efficiency while helping laboratories meet stringent regulatory standards and long-term tissue storage requirements.

The acquisition includes an upfront cash payment of €154 million, with an additional earn-out of up to €121 million linked to performance through 2028. Dreampath is expected to generate revenue of €33 million in the year ending March 2027. Following completion, Halma will operate the business independently within its Healthcare Sector, expanding its diagnostics portfolio with advanced tissue sample traceability and lifecycle management technology. The company believes the acquisition will reinforce its healthcare capabilities and position it to benefit from increasing demand for safer and more efficient diagnostic services.

Halma’s investment case continues to be supported by strong financial execution, including an upbeat earnings update featuring higher guidance and improved margins. However, this is balanced by weaker short-term technical indicators, with the shares remaining below key moving averages, as well as a relatively demanding valuation reflected in a high price-to-earnings ratio and modest dividend yield.

More about Halma plc

Halma plc is a UK-listed international group of technology businesses focused on improving safety, protecting the environment and advancing healthcare. Operating across more than 20 countries, the company provides products and services that help safeguard people and infrastructure, monitor vital resources, and enhance the diagnosis, treatment and delivery of healthcare worldwide.

The minutes from the Fed’s last meeting are due on Wednesday, and on paper, there’s not much reason to expect any major dovish surprises. The statement, the dot plot, and policymakers’ comments all pointed to inflation still being a concern, and another rate hike remained very much on the table. On top of that, Kevin Warsh mentioned that the Fed shouldn’t let its guard down too soon.

The good news is that a lot has changed since that meeting: geopolitical tensions have eased, oil prices have pulled back, gasoline prices are falling, and inflation expectations have started moving in the right direction, with consumers seeing inflation averaging 4.6% over the next year, down from 4.8% in May, while five-year expectations have fallen from 3.9% to 3.3%. Last but not least, the June jobs report came in weak, with just 57,000 jobs added, far below expectations. 

Yet money markets are still pricing in a 25-basis-point hike by December, and the 10-year Treasury yield rose last Thursday from 4.37% to 4.49%, suggesting the market isn’t expecting a quick shift in Fed rhetoric.

But let’s imagine the next few weeks play out in the Fed’s favor: the situation in the Middle East remains relatively calm, with the Strait of Hormuz half-open but still operating, oil continues to drift lower, and inflation comes in softer than expected, increasing the chances of a shift toward a more dovish stance. Who stands to benefit the most?

Bonds would likely be first in line. If markets become convinced the hiking cycle is over, Treasury yields should fall, pushing bond prices higher. Gold (XAUUSD) and other precious metals, including silver (XAGUSD),  would likely follow. Then there’s Big Tech, as lower discount rates tend to boost the value of future earnings.

But of course, for that to happen the data shouldn’t disappoint, but even with gasoline prices coming down, the impact won’t be immediate. 

Italian Investor Acquires Minority Stake in Project Vehicle

Beacon Energy (LSE:BCE) has announced that an Italian energy distribution company has invested €1.4 million in LNEnergy Italy, acquiring an approximately 10% stake in the project company.

Following the transaction, LNEnergy Limited will continue to own the remaining 90% of LNEnergy Italy.

At the same time, LNEnergy Italy has increased its working interest in the Colle Santo gas project from 90% to 100% after one of its existing partners agreed to exit the licence.

Beacon Retains Indirect Economic Interest

Beacon’s exposure to the Colle Santo development is held indirectly through LNE IOM Limited and LNEnergy Limited.

The company said it continues to hold a 43.2% indirect economic interest in the project, subject to the completion of the second acquisition outlined in its admission document dated 17 February 2026.

According to an independent valuation by RPS Energy Limited, Beacon’s indirect interest carries a net present value of €37.6 million using a gas price assumption of €40 per megawatt-hour, rising to €52.9 million at €50 per megawatt-hour, assuming the second acquisition is completed.

Project Advances Toward Production Approval

The Colle Santo gas project received Environmental Impact Assessment (VIA) approval in August 2025, followed by full Environmental Impact Assessment approval in January 2026.

LNEnergy Italy is now focused on obtaining the project’s production concession as it progresses toward development.

Management Welcomes Strategic Backing

Chief Executive Officer Stewart MacDonald said the latest investment demonstrates growing confidence in the project.

“The investment further validates the quality of the Colle Santo project and strengthens the financial backing for the project.”

The additional funding is expected to support continued development of Colle Santo while leaving Beacon’s indirect economic exposure to the project unchanged.

Bullion Gives Back Some Recent Gains

Spot gold edged lower on Monday as the U.S. dollar recovered after last week’s decline, with investors remaining cautious ahead of the release of the Federal Reserve’s latest meeting minutes.

The precious metal retreated after staging a strong rebound from eight-month lows during the previous week, while the greenback bounced from near two-week lows.

By 11:43 GMT, spot gold was down 0.5% at $4,154.14 an ounce, while gold futures rose 1.0% to $4,166.76 an ounce.

David Morrison, Senior Market Analyst at Trade Nation, said:

“The greenback has bounced back this morning, knocking gold lower. Time will tell if this drop proves to be short-lived, or more significant.”

Softer Payrolls Boosted Gold Last Week

Gold advanced more than 2% last week, ending its first positive week since mid-May after weaker-than-expected U.S. employment data prompted investors to scale back expectations for additional Federal Reserve rate increases.

Markets continue to view inflation and labour market conditions as the key indicators shaping future monetary policy decisions.

Higher borrowing costs generally reduce the appeal of gold because the metal offers no yield, making interest-bearing assets relatively more attractive.

Precious Metals Trade Lower

Silver and platinum also weakened on Monday after posting solid gains in the previous week.

Spot silver declined 1.1% to $61.7430 an ounce, while spot platinum slipped 0.4% to $1,635.31 an ounce.

Interest Rate Outlook Remains in Focus

The U.S. Dollar Index gained 0.1% as traders reassessed expectations for future Federal Reserve policy.

Although oil prices have retreated, easing some inflation concerns, investors continue to monitor the potential impact of artificial intelligence-related investment and broader price pressures on the inflation outlook.

Attention now turns to the minutes from the Fed’s June policy meeting, which could provide additional clues about whether policymakers still expect at least one more interest rate increase this year.